255 related articles for article (PubMed ID: 1359120)
1. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
Tanigawara Y; Okamura N; Hirai M; Yasuhara M; Ueda K; Kioka N; Komano T; Hori R
J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
[TBL] [Abstract][Full Text] [Related]
2. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
Okamura N; Hirai M; Tanigawara Y; Tanaka K; Yasuhara M; Ueda K; Komano T; Hori R
J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
[TBL] [Abstract][Full Text] [Related]
3. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
Ito T; Yano I; Tanaka K; Inui KI
J Pharmacol Exp Ther; 1997 Aug; 282(2):955-60. PubMed ID: 9262363
[TBL] [Abstract][Full Text] [Related]
4. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney.
Hori R; Okamura N; Aiba T; Tanigawara Y
J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798
[TBL] [Abstract][Full Text] [Related]
5. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.
Batrakova EV; Miller DW; Li S; Alakhov VY; Kabanov AV; Elmquist WF
J Pharmacol Exp Ther; 2001 Feb; 296(2):551-7. PubMed ID: 11160643
[TBL] [Abstract][Full Text] [Related]
6. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
7. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.
Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J
Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933
[TBL] [Abstract][Full Text] [Related]
8. Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes.
Ohtomo T; Saito H; Inotsume N; Yasuhara M; Inui KI
J Pharmacol Exp Ther; 1996 Mar; 276(3):1143-8. PubMed ID: 8786545
[TBL] [Abstract][Full Text] [Related]
9. Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents.
Woodland C; Koren G; Wainer IW; Batist G; Ito S
Can J Physiol Pharmacol; 2003 Aug; 81(8):800-5. PubMed ID: 12897809
[TBL] [Abstract][Full Text] [Related]
10. Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs.
Leung S; Bendayan R
Can J Physiol Pharmacol; 1999 Aug; 77(8):625-30. PubMed ID: 10543726
[TBL] [Abstract][Full Text] [Related]
11. Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein.
Iwaki K; Sakaeda T; Kakumoto M; Nakamura T; Komoto C; Okamura N; Nishiguchi K; Shiraki T; Horinouchi M; Okumura K
J Pharm Pharmacol; 2006 Dec; 58(12):1617-22. PubMed ID: 17331325
[TBL] [Abstract][Full Text] [Related]
12. Distinct characteristics of transcellular transport between nicotine and tetraethylammonium in LLC-PK1 cells.
Takami K; Saito H; Okuda M; Takano M; Inui KI
J Pharmacol Exp Ther; 1998 Aug; 286(2):676-80. PubMed ID: 9694920
[TBL] [Abstract][Full Text] [Related]
13. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules.
Imaoka T; Kusuhara H; Adachi-Akahane S; Hasegawa M; Morita N; Endou H; Sugiyama Y
J Am Soc Nephrol; 2004 Aug; 15(8):2012-22. PubMed ID: 15284287
[TBL] [Abstract][Full Text] [Related]
14. Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein.
Keogh JP; Kunta JR
Eur J Pharm Sci; 2006 Apr; 27(5):543-54. PubMed ID: 16406207
[TBL] [Abstract][Full Text] [Related]
15. Heterologous expression of various P-glycoproteins in polarized epithelial cells induces directional transport of small (type 1) and bulky (type 2) cationic drugs.
Smit JW; Weert B; Schinkel AH; Meijer DK
J Pharmacol Exp Ther; 1998 Jul; 286(1):321-7. PubMed ID: 9655875
[TBL] [Abstract][Full Text] [Related]
16. Role of P-glycoprotein in accumulation and cytotoxicity of amrubicin and amrubicinol in MDR1 gene-transfected LLC-PK1 cells and human A549 lung adenocarcinoma cells.
Hira A; Watanabe H; Maeda Y; Yokoo K; Sanematsu E; Fujii J; Sasaki J; Hamada A; Saito H
Biochem Pharmacol; 2008 Feb; 75(4):973-80. PubMed ID: 18054347
[TBL] [Abstract][Full Text] [Related]
17. From bench to bedside: utilization of an in vitro model to predict potential drug-drug interactions in the kidney: the digoxin-mifepristone example.
Woodland C; Koren G; Ito S
J Clin Pharmacol; 2003 Jul; 43(7):743-50. PubMed ID: 12856388
[TBL] [Abstract][Full Text] [Related]
18. Enhanced transepithelial flux of cimetidine by Madin-Darby canine kidney cells overexpressing human P-glycoprotein.
Pan BF; Dutt A; Nelson JA
J Pharmacol Exp Ther; 1994 Jul; 270(1):1-7. PubMed ID: 7913494
[TBL] [Abstract][Full Text] [Related]
19. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
Wakasugi H; Yano I; Ito T; Hashida T; Futami T; Nohara R; Sasayama S; Inui K
Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
[TBL] [Abstract][Full Text] [Related]
20. Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line.
Decorti G; Peloso I; Favarin D; Klugmann FB; Candussio L; Crivellato E; Mallardi F; Baldini L
J Pharmacol Exp Ther; 1998 Jul; 286(1):525-30. PubMed ID: 9655898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
